A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis
Clinical trial NCT04486716 · COMPLETED
Trial details
- NCT number
- NCT04486716
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2023-11-20
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.